308 related articles for article (PubMed ID: 31966856)
1. The analysis of clinicopathologic predictors of lymph node metastasis and postoperative recurrence in patients with papillary thyroid microcarcinoma from Guangdong Province, China-a multicenter retrospective study.
He LY; Chen ML; Wang WW; Balde AI; Li Z; Cai Z; Han S; Lei ST; Zhou MW; Zhang GQ
Int J Clin Exp Pathol; 2017; 10(9):9735-9743. PubMed ID: 31966856
[TBL] [Abstract][Full Text] [Related]
2. Lateral lymph node metastasis in papillary thyroid microcarcinoma: a study of 5241 follow-up patients.
Ruan J; Chen Z; Chen S; Xu Z; Wen L; Mao Z; Shen J; Liu J; Wang W
Endocrine; 2024 Feb; 83(2):414-421. PubMed ID: 37596455
[TBL] [Abstract][Full Text] [Related]
3. Clinical and pathologic predictors of lymph node metastasis in papillary thyroid microcarcinomas.
Zhao L; Sun X; Luo Y; Wang F; Lyu Z
Ann Diagn Pathol; 2020 Dec; 49():151647. PubMed ID: 33126150
[TBL] [Abstract][Full Text] [Related]
4. Risk prediction and clinical model building for lymph node metastasis in papillary thyroid microcarcinoma.
Lin DZ; Qu N; Shi RL; Lu ZW; Ji QH; Wu WL
Onco Targets Ther; 2016; 9():5307-16. PubMed ID: 27601922
[TBL] [Abstract][Full Text] [Related]
5. Determine the Optimal Extent of Thyroidectomy and Lymphadenectomy for Patients With Papillary Thyroid Microcarcinoma.
Feng JW; Pan H; Wang L; Ye J; Jiang Y; Qu Z
Front Endocrinol (Lausanne); 2019; 10():363. PubMed ID: 31275239
[No Abstract] [Full Text] [Related]
6. Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma.
Siddiqui S; White MG; Antic T; Grogan RH; Angelos P; Kaplan EL; Cipriani NA
Thyroid; 2016 Jun; 26(6):807-15. PubMed ID: 27117842
[TBL] [Abstract][Full Text] [Related]
7. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
8. Identification of risk factors of central lymph node metastasis and evaluation of the effect of prophylactic central neck dissection on migration of staging and risk stratification in patients with clinically node-negative papillary thyroid microcarcinoma.
Yuan J; Li J; Chen X; Lin X; Du J; Zhao G; Chen Z; Wu Z
Bull Cancer; 2017 Jun; 104(6):516-523. PubMed ID: 28476312
[TBL] [Abstract][Full Text] [Related]
9. Clinical and pathologic predictors of central lymph node metastasis in papillary thyroid microcarcinoma: a retrospective cohort study.
Gui CY; Qiu SL; Peng ZH; Wang M
J Endocrinol Invest; 2018 Apr; 41(4):403-409. PubMed ID: 28884301
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological features for predicting central and lateral lymph node metastasis in papillary thyroid microcarcinoma: Analysis of 66 cases that underwent central and lateral lymph node dissection.
Tao Y; Wang C; Li L; Xing H; Bai Y; Han B; Liu Z; Yang X; Zhu S
Mol Clin Oncol; 2017 Jan; 6(1):49-55. PubMed ID: 28123728
[TBL] [Abstract][Full Text] [Related]
11. Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution.
Xu Y; Xu L; Wang J
J Surg Res; 2018 Jan; 221():128-134. PubMed ID: 29229118
[TBL] [Abstract][Full Text] [Related]
12. Clinical Analysis of Risk Factors for Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study of 3686 Patients.
Song J; Yan T; Qiu W; Fan Y; Yang Z
Cancer Manag Res; 2020; 12():2523-2530. PubMed ID: 32308489
[TBL] [Abstract][Full Text] [Related]
13. Management of cN0 papillary thyroid microcarcinoma patients according to risk-scoring model for central lymph node metastasis and predictors of recurrence.
Feng JW; Ye J; Wu WX; Qu Z; Qin AC; Jiang Y
J Endocrinol Invest; 2020 Dec; 43(12):1807-1817. PubMed ID: 32557354
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Findings Associated With Cervical Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Retrospective Study in China.
Shi Y; Yang Z; Heng Y; Ju H; Pan Y; Zhang Y
Cancer Control; 2022; 29():10732748221084926. PubMed ID: 35285273
[TBL] [Abstract][Full Text] [Related]
15. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
[TBL] [Abstract][Full Text] [Related]
16. Clinical and ultrasonic risk factors for high-volume central lymph node metastasis in cN0 papillary thyroid microcarcinoma: A retrospective study and meta-analysis.
Wang Z; Gui Z; Wang Z; Huang J; He L; Dong W; Zhang D; Zhang T; Shao L; Shi J; Wu P; Ji X; Zhang H; Sun W
Clin Endocrinol (Oxf); 2023 Apr; 98(4):609-621. PubMed ID: 36263602
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors for central lymph node and lateral cervical lymph node metastases in papillary thyroid carcinoma.
Feng JW; Yang XH; Wu BQ; Sun DL; Jiang Y; Qu Z
Clin Transl Oncol; 2019 Nov; 21(11):1482-1491. PubMed ID: 30879178
[TBL] [Abstract][Full Text] [Related]
18. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
Back K; Kim JS; Kim JH; Choe JH
Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis.
Wen X; Jin Q; Cen X; Qiu M; Wu Z
World J Surg Oncol; 2022 Apr; 20(1):106. PubMed ID: 35365171
[TBL] [Abstract][Full Text] [Related]
20. Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta-Analysis.
Qu N; Zhang L; Ji QH; Chen JY; Zhu YX; Cao YM; Shen Q
World J Surg; 2015 Oct; 39(10):2459-70. PubMed ID: 26099728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
